Laura Palagini, Gaspare Alfi, Riccardo Gurrieri, Eric Annuzzi, Valerio Caruso, Matteo Gambini, Giovanna Grenno, Marco Trivella, Silvio Presta, Mario Miniati, Stefano Pini, Giulio Perugi, Angelo Gemignani
Insomnia disorder may affect mental health, increasing suicidal risk. Targeting insomnia is crucial in the clinical practice. Sixty-six consecutive patients with insomnia disorder according with the DSM-5-TR criteria were treated with the dual orexin receptor antagonist, daridorexant 50 mg. Baseline (T0), 1 month (T1) and 3 month (T2) evaluations were performed. Insomnia severity (Insomnia Severity Index), mood, anxiety symptoms and suicidal risk (Beck Depression Inventory-II, Young Mania Rating Scale, Self-Reported Anxiety Scale, Suicidal Ideation Scale), dysfunctional insomnia-cognitive factors and pre-sleep arousal (Dysfunctional Beliefs About Sleep, Pre-Sleep Arousal Scale) were evaluated...
March 24, 2024: Journal of Sleep Research